Task: Answer the multiple-choice question.
Question: Which drug exhibits a 22.344% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) CN(C(=O)c1ccco1)c1nc(CC(=O)Nc2ccccc2)cs1
(b) CC(NC(=O)c1ccccc1F)c1nnc(SCC(=O)NC2=NCCS2)n1C
(c) CC(C)COc1ccc(Cc2c(O)[nH]c(=S)[nH]c2=O)cc1
(d) CN(C)P1(N(C)C)=NC(C(F)(F)F)=NC(C(F)(F)F)=N1
(e) Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc4c(c3)OCO4)CC2)cc1
Answer: b. CC(NC(=O)c1ccccc1F)c1nnc(SCC(=O)NC2=NCCS2)n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(NC(=O)c1ccccc1F)c1nnc(SCC(=O)NC2=NCCS2)n1C
CC(NC(=O)c1ccccc1F)c1nnc(SCC(=O)NC2=NCCS2)n1C
N-[1-[5-[2-(4,5-dihydro-1,3-thiazol-2-ylamino)-2-oxoethyl]sulfanyl-4-methyl-1,2,4-triazol-3-yl]ethyl]-2-fluorobenzamide